A mathematical model of breast cancer treatment with CMF and doxorubicin

DOI10.1007/S11538-010-9549-9MaRDI QIDQ644402zbMATH OpenOpenAlexWikidataFDO

Authors Rachel Roe-Dale, David Isaacson, Michael Kupferschmid

Publication date 4 November 2011

Published in Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1007/s11538-010-9549-9

zbMATH Keywords

cell cycledrug resistancedrug order

Mathematics Subject Classification ID

Medical applications (general) (92C50) Biochemistry, molecular biology (92C40) Dynamical systems in biology (37N25) Probabilistic models, generic numerical methods in probability and statistics (65C20) Cell biology (92C37)

Recommendations

• Mathematical model of triple-negative breast cancer in response to combination chemotherapies
• A mathematical model of breast and ovarian cancer treated with Paclitaxel
• Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters
• A mathematical model of cancer treatment by chemotherapy
• A mathematical model of breast cancer development, local treatment and recurrence
• A mathematical model of chemotherapy response to tumour growth
• Some mathematical models for cancer chemotherapy
• A mathematical model of cancer chemotherapy with an optimal selection of parameters
• Mathematical model for the estrogen paradox in breast cancer treatment

Cites work

• scientific article; zbMATH DE number 425863 (Why is no real title available?)
• scientific article; zbMATH DE number 4066244 (Why is no real title available?)
• scientific article; zbMATH DE number 42769 (Why is no real title available?)
• A mathematical model of cycle-specific chemotherapy
• A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance

Cited in

(14)

• Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures
• A mathematical model of doxorubicin penetration through multicellular layers
• A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results
• Mathematical model of triple-negative breast cancer in response to combination chemotherapies
• Mathematical model for the estrogen paradox in breast cancer treatment
• A mathematical model of cell cycle effects in gastric cancer chemotherapy
• Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines
• Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line
• Modelling the Effects of Paclitaxel and Cisplatin on Breast and Ovarian Cancer
• Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent
• Optimizing combination therapy in a murine model of HER2+ breast cancer
• USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS
• Mathematics + cancer: an undergraduate ``bridge course in applied mathematics
• Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib

This page was built for publication: A mathematical model of breast cancer treatment with CMF and doxorubicin

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q644402)